Loading the map…
Research and experimental development on biotechnology · Huntingdon
Apini Therapeutics
Apini Therapeutics Limited
Private limited company registered in Huntingdon, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Mar 2026 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|
| Profit after tax | — | |||
| Turnover | ||||
| Net assets | ||||
| Cash | ||||
| Employees | ||||
| Retained reserves |
Every figure for all 4 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Creditors due after a year | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
8 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-24
- SharesStatement of capital following an allotment of shares on 4 August 2026 · GBP 56.85144 (and 3 more like it since 17 August 2022)
- AccountsAccounts for a small company made up to 31 March 2026
- DirectorsAppointment of Dr John Timothy Roger Isaac as a director on 7 November 2025
- DirectorsTermination of appointment of Richard Wooster as a director on 7 November 2025
- NameReplacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144
- OwnershipChange of details for Slingshot Therapeutics Holdings Limited as a person with significant control on 8 July 2025
- AccountsAccounts for a small company made up to 31 March 2025
- FilingResolutions (and 3 more like it since 19 August 2022)
- FilingMemorandum and Articles of Association (and 2 more like it since 19 August 2022)
- DirectorsDirector's details changed for Mr James Gibbons on 27 March 2025
- DirectorsAppointment of Mr James Gibbons as a director on 27 March 2025
- DirectorsAppointment of Dr Susan Jane Herbert as a director on 3 December 2024
13 earlier
- OwnershipChange of details for Syncona Nexus Holdings Ltd as a person with significant control on 13 September 2024
- AccountsCurrent accounting period extended from 30 November 2024 to 31 March 2025
- AddressRegistered office address changed from C/O Umif 46 Grafton Street Manchester M13 9NT England to Burnham House Splash Lane Wyton Huntingdon PE28 2AF on 28 September 2024
- DirectorsAppointment of Archangel Accounting Limited as a secretary on 27 September 2024
- SharesSub-division of shares on 13 August 2024
- OwnershipCessation of Sam Butterworth as a person with significant control on 13 August 2024
- OwnershipNotification of Syncona Nexus Holdings Ltd as a person with significant control on 13 August 2024
- DirectorsAppointment of Dr Nathaniel Dahan as a director on 13 August 2024
- DirectorsAppointment of Dr Richard Wooster as a director on 13 August 2024
- OwnershipChange of details for Dr. Sam Butterworth as a person with significant control on 27 July 2022
- AccountsMicro company accounts made up to 30 November 2023
- AccountsMicro company accounts made up to 30 November 2022
- IncorporationIncorporation
- Ownership
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Apini Therapeutics do?
Private limited company registered in Huntingdon, classed under “Research and experimental development on biotechnology”.
›How much turnover does Apini Therapeutics make?
Answered in the full report
›Is Apini Therapeutics profitable?
Apini Therapeutics's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Apini Therapeutics?
Answered in the full report
›Who runs and owns Apini Therapeutics?
Its directors are Archangel Accounting Limited, Sam Butterworth, Nathaniel Dahan, James Gibbons, Susan Jane Herbert and 1 more. Its owners are shown to subscribers.
›Where is Apini Therapeutics based?
Its registered office is Burnham House Splash Lane, Wyton, Huntingdon, PE28 2AF, in Huntingdon.
›When was Apini Therapeutics founded?
Apini Therapeutics Limited was incorporated on 26 November 2021.
›Is Apini Therapeutics still trading?
The register lists Apini Therapeutics Limited as active.